Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 1 2Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 1Dupuytren Contracture 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Microbial Collagenase × Clear all
NCT02889848 2019-07-10

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Advance Biofactures Corporation

Phase 1 Completed
15 enrolled

Leiomyoma

NCT00528931 2017-10-05

A Pharmacokinetic Study of AA4500 (XIAFLEXâ„¢, Proposed Name) in Subjects With Dupuytren's Contracture

Endo Pharmaceuticals

Phase 1 Completed
16 enrolled 11 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡